Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 24, Issue 3, 2004, Pages 247-249

  Liu, Wenbin ^a   Li, Jiawen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antigen; CD80; CD86; CTLA 4; Lupus erythematosus, systemic

Indexed keywords

ANTIGENS; BLOOD; CELLS; RNA; STATISTICAL METHODS;

CD80; CD86; CTLA-4; LUPUS ERTHYEMATOSUS;

GENETIC ENGINEERING;

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 27644529714     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bijl M, Horst G, Limburg P C et al. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis, 2001, 60(5):523
2. Nagafuchi H, Shimoyama Y, Kashiwakura J et al. Enhanced CD86 expression of B cells by CD40L is essential for polyclonal antibody production. Clin Exp Rheumatol, 2003, 21(1):71
3. Bombardier C, Gladman D D, Urowitz M B et al. Derivation of the SLEDAI: a disease activity index for lupus patients: The Committee on prognosis studies in SLE. Arthritis Rheum, 1992, 35:630
4. Guerder S, Meyerhoff J, Flavell R. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity, 1994, 1:155
5. Schweitzer A N, Sharpe A H. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimultion of Th2 but not Th1 cytokine production. J Immunol, 1998, 161:2762
6. Funauchi M, Yoo B S, Nozaki Y et al. Lupus dysregulation of the granulocyte-macrophage colony-stimulating factor receptor is one of the causes of defective expression of CD80 antigen in systemic lupus erythematosus. 2002, 11(5):317
7. Denfeld R W, Kind P, Sontheimer R D et al. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum, 1997, 40(5):814
8. Lee K M, Chuang E, Griffin M et al. Molecular basis of T cell inactivation by CTLA-4. Science, 1998, 282:2263
9. Khatlani T S, Ma Z, Okuda M et al. Autoantibodies against T-Cell costimulatory molecules are produced in canine autoimmune diseases. J Immunother, 2003, 26(1):12
10. (15) Oaks M K, Hallett K M. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol, 2000, 164:5015